Project Grant SB1EB038130
- The Defense Health Agency awarded Infinite Biomedical Technologies, LLC $3.008 million on August 1, 2026, through the Military Medical Research and Development program (CFDA 12.420) to optimize the glide control strategy for individuals with partial hand limb loss. The project runs through July 31, 2030, with performance in Baltimore, Maryland. Infinite Biomedical Technologies specializes in advanced prosthetic technologies and rehabilitation systems for upper-limb loss. The company develops...
- The National Institute of Neurological Disorders and Stroke awarded Neurorobotic Technologies, LLC $500,000 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and assess a powered prosthetic digit system that integrates wrist-based motor control with sensory feedback for individuals with partial hand limb loss. The project will integrate four independently developed components into a single prosthetic...
- The Defense Health Agency awarded a $2,356,273 Project Grant to Infinite Biomedical Technologies, LLC (I.b.t.) under the Military Medical Research and Development program (CFDA 12.420). The grant aims to determine the long-term stability of the glide control strategy for upper limb prostheses. I.b.t., a minority-owned for-profit company specializing in advanced prosthetic technologies and rehabilitation systems, will conduct the research and development project from May 1, 2025, through April...
- The National Science Foundation (NSF) awarded the University of Alabama a $549,546 Project Grant under the Partnerships for Innovation - Research Partnerships (PFI-RP) program (CFDA 47.084). The 3-year project (08/01/2023 - 07/31/2026) aims to develop an affordable, powered lower-limb prosthetic device that provides versatile multi-modal operation to significantly improve mobility and quality of life for amputees. Key innovations include a novel common-core-components knee-ankle prosthesis...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded $1.696 million to Poly Orth International on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds translational pre-clinical research and development of a 3D-printed skin and bone integrated pylon (SBIP-3D) for direct skeletal attachment of limb prostheses. The technology, developed by Poly Orth International, integrates with both residual bone...
- This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Orthomechanica, Inc., a small minority-owned business located in Corvallis, OR. The funding supports the design, engineering, and preclinical validation of a novel implantable medical device that aims to improve functional outcomes for over 100,000 patients annually undergoing reconstructive surgery. The device integrates a...
- The National Institute of Biomedical Imaging and Bioengineering awarded Brigham & Women's Hospital Inc. $1,583,125 on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a multifunctional interventional device for biopsy and optical imaging-based phase-0 drug response measurements. The recipient will develop an interventional drug response assay (IDRA) device to enable biopsy-based phase-0 measurements...
- The National Science Foundation awarded Modular Matter, Inc. $305,000 on October 1, 2026, under NSF Technology, Innovation, and Partnerships (CFDA 47.084) to develop a universally adjustable, modular prosthesis socket system. The recipient will design and prototype expandable, modular components fabricated using selective laser sintering that can be assembled, configured, and reconfigured to accommodate individual limb shapes and volume fluctuations. The system targets both upper and lower...
- This $549,195 Project Grant, awarded April 1, 2025, by the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering program (CFDA 47.041), supports the development of a minimally invasive implantable optical tactile sensor designed to restore somatosensory feedback for patients with paralysis from stroke or spinal cord injury. The University of Pennsylvania will deliver an implantable wireless device that uses...
- Summary The University of Michigan received a $605,832 Cooperative Agreement from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded September 15, 2025, with completion targeted for August 31, 2027. The award funds the development and clinical testing of a regenerative peripheral nerve interface (RPNI) control system designed to enable intuitive, multi-articulated...
The National Institute of Biomedical Imaging and Bioengineering awarded Infinite Biomedical Technologies, LLC $362,530 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to advance commercialization readiness for a 3D printed titanium, myoelectric-powered prosthetic digit system. Infinite Biomedical Technologies is developing the Point Powered, a durable myoelectric prosthesis designed for individuals with partial hand limb loss to perform heavy-duty tasks. The award funds late-stage technical assistance focused on optimizing manufacturing processes and preparing for scaled production. Prior Phase I work (R43EB030895) addressed engineering development of frame, transmission, and motor driver components. The ongoing Phase II effort (R44EB030895) focuses on two key features: a novel clutch design enabling tenfold increase in passive load tolerance and a rechargeable power system designed for low-profile integration and single-handed operation. The approximately 700,000 Americans living with partial hand limb loss currently have access to only one myoelectric prosthetic option, which is fragile, limited to light-duty tasks, and too large for most partial hand loss cases. The Point Powered addresses this gap to improve employment prospects and functional capability for this underserved population. Period of performance runs through August 31, 2028, with work performed in Baltimore, Maryland. This is a project grant assistance type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $362.5k | 8/24/26 |